Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride.

No abstract is available for this paper.

• Publication year

  1943

• Venue

  Canadian Medical Association journal

• Publication date

  1943-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s0002-8703(43)90306-0PMID 20322846PMCID PMC1827836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of Nephrosclerosis by Overdosage with Desoxycorticosterone Acetate.

  1942cited by this paper
• ON THE THERAPEUTIC VALUE OF ADRENAL CORTICAL HORMONES IN TRAUMATIC SHOCK AND ALLIED CONDITIONS.

  1940cited by this paper
• The colorimetric determination of sodium.

  1931cited by this paper

• Finerenone in the management of diabetes kidney disease

  2025cites this paper
• The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension

  2024cites this paper
• MINERALOCORTICOID RECEPTORS, MACROPHAGES AND NEW MECHANISMS FOR CARDIOVASCULAR DISEASE.

  2024cites this paper
• Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status.

  2024cites this paper
• Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial

  2024cites this paper
• Chronic Kidney Disease in the Older Adult Patient with Diabetes

  2024cites this paper
• The physiological anti-hypertensive peptide catestatin and its common human variant Gly364Ser: differential cardiovascular effects in a rat model of hypertension

  2024cites this paper
• Cell-specific transcriptome changes in the hypothalamic arcuate nucleus in a mouse deoxycorticosterone acetate-salt model of hypertension

  2023cites this paper
• Roles of the mechanosensitive ion channel Piezo1 in the renal podocyte injury of experimental hypertensive nephropathy

  2023cites this paper
• Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus

  2023cites this paper
• Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges

  2023cites this paper
• The Interaction of Kidneys and Gut in Development of Salt-Sensitive Hypertension

  2023cites this paper
• Cardiometabolic Effects of DOCA-Salt in Mice Depend on Ambient Temperature

  2023cites this paper
• The DOCA-Salt Model of Hypertension for Studies of Cerebrovascular Function, Stroke, and Brain Health.

  2023cites this paper
• Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study

  2022cites this paper
• Elucidation of Anti-Hypertensive Mechanism by a Novel Lactobacillus rhamnosus AC1 Fermented Soymilk in the Deoxycorticosterone Acetate-Salt Hypertensive Rats

  2022cites this paper
• Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms.

  2022cites this paper
• Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease

  2022cites this paper
• Cardiometabolic effects of DOCA-salt in male C57BL/6J mice are variably dependent upon sodium and non-sodium components of diet.

  2022cites this paper
• The adducin saga: Pleiotropic genomic targets for precision medicine in human hypertension; vascular, renal, and cognitive diseases.

  2021cites this paper
• Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present

  2021cites this paper
• Microbiota and Metabolites as Factors Influencing Blood Pressure Regulation.

  2021cites this paper
• Mineralocorticoid Receptor Antagonists in CKD: In Need of a Few Large Trials.

  2021cites this paper
• Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

  2021cites this paper
• Activation of the Central Renin-Angiotensin System Causes Local Cerebrovascular Dysfunction

  2021cites this paper
• Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

  2020influential citation
• Animal Models of Hypertension: A Scientific Statement From the American Heart Association

  2019cites this paper
• Renal damage in primary aldosteronism: a systematic review and meta-analysis.

  2019cites this paper
• Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.

  2017cites this paper
• Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats

  2017cites this paper
• Animal models for the study of primary and secondary hypertension in humans ( Review )

  2016cites this paper
• Animal models for the study of primary and secondary hypertension in humans

  2016cites this paper
• Sex and Gender Differences in Cardiovascular Disease

  2016cites this paper
• Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.

  2015cites this paper
• Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis

  2015cites this paper
• The Medicalization Of Stress: Hans Selye And The Transformation Of The Postwar Medical Marketplace

  2015cites this paper
• The M edicalization Of Stress: Hans Selye And The Transformation Of The P ostwar Medical Marketplace

  2015cites this paper
• CNS Neuroplasticity and Salt Sensitive Hypertension Induced by Prior Treatment with Sub-1 Pressor Doses of Angiotensin II or Aldosterone

  2014cites this paper
• Characterization of Musclin as a New Target for Treatment of Hypertension

  2014cites this paper
• CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone.

  2014cites this paper
• Angiotensin Type 1a Receptors in the Subfornical Organ Are Required for Deoxycorticosterone Acetate-Salt Hypertension

  2013cites this paper
• Arterial Lesions and Arteriosclerosis

  2012cites this paper
• Mineralocorticoids and Hypertension

  2012cites this paper
• Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure

  2012cites this paper
• Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.

  2012cites this paper
• Hyperaldosteronismus und verstärkte Aktivität des Mineralokortikoidrezeptors

  2011cites this paper
• Angiotensinergic Signaling in the Brain Mediates Metabolic Effects of Deoxycorticosterone (DOCA)-Salt in C57 Mice

  2011cites this paper
• The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress

  2010cites this paper
• Extracellular Volume and Aldosterone Interaction in Chronic Kidney Disease

  2009cites this paper
• The combined effect of adrenaline desoxicortone and sodium chloride on blood pressure in the rat.

  2009cites this paper
• Zona Reticularis in Aging Spontaneously Hypertensive Rats

  2007cites this paper
• Experimental Hypertension

  2007cites this paper
• The endocrine system in chronic nitric oxide deficiency.

  2007cites this paper
• Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression.

  2006cites this paper
• Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective

  2006cites this paper
• Hypertension in Rats Bearing an Adrenocorticotropic Hormone-, Growth Hormone-, and Prolactin-secreting Tumor 4 ' AgostinoMolteni

  2006cites this paper
• Effects of Chronic Excess Salt Ingestion

  2005cites this paper
• Effect of Aldosterone and MR Blockade on the Brain and the Kidney

  2005cites this paper
• Aldosterone promotes endothelial dysfunction via prostacyclin independent of hypertension.

  2005cites this paper
• The Renin System and Four Lines of Hypertension Research Nephron Heterogeneity , the Calcium Connection , the Pro renin Vasodilator Limb , and Plasma Renin and Heart Attack

  2005cites this paper
• Aldosterone target organ protection by eplerenone.

  2004cites this paper
• Effects of deoxycorticosterone on renal vascular reactivity and flow-pressure curve in spontaneously hypertensive rats.

  2004cites this paper
• Nierenfunktion bei Ratten mit experimentellem DOCA-Hochdruck

  2004cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone (Inspra).

  2003cites this paper
• Chronic Blockade of Neuronal Nitric Oxide Synthase Does Not Affect Long‐Term Control of Blood Pressure in Normal, Saline‐Drinking or Deoxycorticosterone‐Treated Rats

  2003cites this paper
• Protective effects of dietary potassium chloride on hemodynamics of Dahl salt-sensitive rats in response to chronic administration of sodium chloride

  2003cites this paper
• The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure

  2003cites this paper
• Glucocorticoids and the kidney

  2003cites this paper
• Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.

  2003cites this paper
• Aldosterone as a Mediator in Cardiovascular Injury

  2002cites this paper
• Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading

  2002cites this paper
• Pathophysiological effects of aldosterone in cardiovascular tissues.

  2001cites this paper
• Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension.

  2000cites this paper
• Renal impairment in deoxycorticosterone acetate‐salt hypertensive rats

  2000cites this paper
• Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model.

  2000cites this paper
• Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.

  2000cites this paper
• Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.

  1999cites this paper
• Effect of the heme/heme oxygenase pathway on the relationship between salt consumption and blood pressure

  1998cites this paper
• Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

  1998cites this paper
• Effect of the heme/heme oxygenase pathway on the relationship between salt consumption and blood pressure

  1998cites this paper
• Genetic susceptibility to hypertension-induced renal damage in the rat. Evidence based on kidney-specific genome transfer.

  1997cites this paper
• Models of experimental hypertension in mice.

  1996cites this paper
• Interaction of calcium channel blockers (CCBs) with histamine and 5-hydroxytryptamine in aorta from normal and diseased rats.

  1996cites this paper
• Interaction of calcium channel blockers with different agonists in aorta from normal and diseased rats.

  1996cites this paper
• The role of the kidney in hypertension.

  1996cites this paper
• Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.

  1994cites this paper
• EFFECT OF DIETARY SODIUM CHLORIDE ON THE DEVELOPMENT OF RENAL GLOMERULAR AND VASCULAR LESIONS IN HYPERTENSIVE RATS

  1993cites this paper
• The inhibition of rat adrenal cytochrome P-45011 beta gene expression by androgens.

  1992cites this paper
• The inhibition of rat adrenal cytochrome P-45011β gene expression by androgens

  1992cites this paper
• Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.

  1992cites this paper
• Effects of deoxycorticosterone acetate on glucose metabolism in nondiabetic and streptozotocin-diabetic rats.

  1992cites this paper
• ACTH HYPERTENSION IN THE RAT: ROLE OF KIDNEY AND GONADS

  1991cites this paper
• [Antihypertensive effects of amlodipine, a new calcium antagonist].

  1991cites this paper
• Experimental Hypertension

  1991cites this paper
• Expression of Adrenal Cytochromes P‐450 in Testosterone‐Induced Hypertension

  1991cites this paper
• Renin–Angiotensin–Aldosterone System and the Renal Regulation of Sodium, Potassium, and Blood Pressure Homeostasis

  1991cites this paper
• Effects of dexamethasone on body fluid and electrolyte composition of rats.

  1990cites this paper
• Hormone and electrolyte changes in post-deoxycorticosterone salt hypertension in rats.

  1990cites this paper
• Effects of antimineralocorticoid RU 26752 on steroid-induced hypertension in rats.

  1990cites this paper